Tofranil

What is it?

Composition

Tofranil tablets contain the active ingredient imipramine (as imipramine hydrochloride). Tablets also include inactive excipients used to form and stabilize the pill (fillers, binders, disintegrants, and film-coating components depending on strength).

How to use?

• Route: oral (swallow tablets with water)
• Adults, depression: start 25 mg 2–3 times/day; increase over several days to 100–150 mg/day in divided doses; usual max 200 mg/day
• Maintenance (adults): 50–100 mg once daily, preferably at bedtime
• Older adults: start 10 mg 2–3 times/day; increase cautiously; typical total 30–100 mg/day in divided doses
• Enuresis (children ≥6 years): 25 mg once daily at bedtime; if needed increase after 1–2 weeks to 50 mg (ages 7–12) or 75 mg (older children); max 75 mg/day
• Timing with meals: may take with or after food if stomach upset occurs; bedtime dosing may reduce daytime drowsiness
• Duration: antidepressant courses are typically several months; for enuresis, reassess after 1–3 months and taper if stopping

How does it work?

• Route: oral (tablets)
• Typical adult antidepressant regimen: 25 mg 2–3 times/day, titrate to 100–150 mg/day (max 200 mg/day), then 50–100 mg at bedtime for maintenance
• Dosing pattern for sedating effects: if daytime sleepiness occurs, shift a larger portion of the total daily dose to bedtime while keeping the same total mg/day
• Duration of effect: symptom improvement is typically assessed after 2–4 weeks at a therapeutic dose; continue treatment for several months if effective
• Mechanism at therapeutic dosing: imipramine inhibits neuronal reuptake of serotonin and norepinephrine, increasing synaptic levels; anticholinergic effects may contribute to both benefits and side effects

Indications

Tofranil is primarily used to treat:

• Depression (including major depressive episodes)
• Other psychiatric conditions where a tricyclic antidepressant is selected by the prescriber (for example, depression with anxiety features)

Tofranil can be used in nocturnal enuresis in children under medical supervision. The goal is not sedation; it is an effect on bladder control and sleep-arousal pathways that can reduce bedwetting episodes in selected patients. This use is usually time-limited, and clinicians watch closely for side effects like constipation, sleep changes, and fast heartbeat.

Comparison

Doctors choose among antidepressants based on symptom profile, medical history, and side effect tolerance. Tofranil is a tricyclic antidepressant, while many first-line modern options are SSRIs or SNRIs.

Here is a high-level comparison of options a prescriber may consider:

Switching antidepressants is not a self-directed change. Cross-tapering plans exist for safety, and washout timing matters most when MAOIs are involved.

Contraindications

• Hypersensitivity to imipramine
• Acute post–myocardial infarction period
• Certain heart rhythm disorders or severe cardiovascular disease
• Closed-angle glaucoma
• Severe liver failure
• Severe kidney failure
• Concomitant use of MAO inhibitors (or very recent MAOI use)

Not recommended for

Do not use Tofranil if:

• You are allergic to imipramine
• You have had a recent heart attack
• You have significant heart rhythm problems or serious heart disease
• You have closed-angle glaucoma
• You have severe liver or kidney problems
• You take MAO inhibitors, or have taken them very recently

Be especially cautious and discuss with your clinician if you have epilepsy, bipolar disorder, are an older adult, or have a history of suicidal thoughts. Pregnancy and breastfeeding require an individualized risk–benefit discussion with your prescriber.

Side effects

Side effects are dose-related and often strongest in the first 1–2 weeks, then improve. With tricyclic antidepressants, the most common issues are driven by anticholinergic and antihistamine activity.

Common side effects include:

• Dry mouth and taste changes
• Constipation, nausea, stomach discomfort
• Dizziness, drowsiness, reduced concentration
• Fast heartbeat (tachycardia) or awareness of heartbeat
• Increased sweating
• Weight gain (less often weight loss)

Less common but serious side effects need fast clinical attention, because they can be medically significant:

• Abnormal heart rhythms (risk is higher in people with existing cardiac disease)
• Seizures (risk rises with higher doses or predisposition)
• Marked drop in blood pressure, fainting

One sentence that matters for daily life: driving can feel fine one day and unsafe the next early in treatment, especially after a dose increase.

A second practical nuance: blurred vision with tricyclics is often “focusing difficulty” rather than eye damage, yet it can be dangerous if you drive at night.

Common mistakes

A lot of “it didn’t work” stories are actually use-pattern problems.

Common mistakes I see repeatedly:

• Stopping suddenly once sleep improves, then getting rebound insomnia, irritability, and flu-like withdrawal symptoms.
• Doubling the next dose after forgetting one, which often causes dizziness and a racing heart later that day.
• Taking the full dose in the morning when sedation is strong, then struggling at work and quitting early.
• Under-treating constipation, which can become severe with tricyclic antidepressants.
• Mixing with sedatives or alcohol on stressful nights, leading to unsafe impairment and worse next-day mood.

One sentence of pharmacy reality: if side effects show up, most can be managed, but only if they’re addressed early and specifically.

Doctor opinions

Psychiatrists and family physicians often describe Tofranil as a “workhorse” tricyclic: effective for many patients, but less forgiving on side effects than SSRIs. In day-to-day prescribing, clinicians frequently choose it when depression is mixed with insomnia or agitation, while still screening for cardiac risk factors first.

Dose titration is where experience shows. Many doctors intentionally increase slowly, because a rapid jump can trigger palpitations, constipation, and morning grogginess that looks like intolerance but is really speed of escalation. One clinical habit that helps: checking baseline cardiovascular history before pushing dose, and re-checking if new fainting, chest discomfort, or sustained tachycardia appears.

A trade-off clinicians mention openly: TCAs can be very effective, yet they demand more respect around interactions and overdose risk than many newer antidepressants.

Frequently asked questions

How long does Tofranil take to work for depression?

Early effects like sedation or reduced anxiety can appear in the first several days, but mood improvement usually takes longer. Many people notice clearer benefit after 1–2 weeks, with fuller response often assessed at 4–6 weeks. This matches how antidepressant outcomes are evaluated in clinical guidance used across Europe. Reference point: EMA-reviewed antidepressant assessment standards. ^[5]

Is Tofranil used for anxiety or sleep problems?

Clinicians sometimes choose Tofranil when depression includes anxiety symptoms and sleep disruption, because its pharmacology can be calming. The benefit is counterbalanced by anticholinergic side effects and next-day drowsiness in some patients. Treatment choice also depends on cardiac risk and interaction profile. In 2026, MOHAP-aligned prescribing practice in the UAE generally mirrors these risk–benefit considerations.

Can Tofranil be used for nocturnal enuresis in children?

Yes, it can be prescribed for nocturnal enuresis in children under close medical supervision. Dosing is individualized and tends to be time-limited, with careful monitoring for side effects like constipation, sleep changes, and palpitations. Clinicians also rule out constipation and sleep apnea, since both can mimic or worsen bedwetting. WHO child-health frameworks used in 2026 emphasize combining medication, behavioural strategies, and safety monitoring.

What should I avoid while taking Tofranil?

Avoid MAO inhibitors, including Nardil and Marplan, because the interaction risk is severe and can be dangerous. Many people also need to avoid combining with sedatives that intensify drowsiness and impair coordination. If you are on medicines that affect heart rhythm, the prescriber usually reviews the full list before starting. This approach aligns with EMA safety communications for tricyclic antidepressants in 2026.

Does Tofranil cause weight gain or sexual side effects?

Weight gain can happen with tricyclic antidepressants, though not everyone experiences it, and appetite changes can go either direction. Sexual side effects are possible with many antidepressants, but the pattern varies widely by person and dose. If the benefit is good but weight is creeping up, clinicians often adjust timing, dose, or lifestyle levers rather than stopping abruptly. In 2026, WHO guidance on depression management supports proactive side-effect management to improve adherence.

Is Tofranil safe for people with heart conditions?

People with recent myocardial infarction, significant arrhythmias, or severe cardiovascular disease are generally not candidates for Tofranil. Even in milder cardiac history, clinicians may be cautious because tricyclic antidepressants can affect heart rhythm and blood pressure. New palpitations, fainting, or chest discomfort during treatment should trigger prompt medical review. This risk framing is consistent with EMA safety information for imipramine-class medicines.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.